Although the mechanisms by which PNPLA3 polymorphism links to HCC has not completely known, it is anticipated that this genetic variant might promote hepatocarcinogenesis via metabolic disorders including obesity, diabetes, and steatohepatitis [19]. Here, PNPLA3 is linked to obesity due to melanocortin 4 receptor deficiency.